IEX •
Healthcare •
Biotechnology •
Quote as of 06/16/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization853.36 mln
Float121 mln
Earnings Date07/30/2026
EPS
0.83
Decent
P / E
5.29
Undervalued
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
31.08
Highly suspicious
1-Year Forecast
5.13
Attractive
Relative Strength
75
/ 100
Strongly outperforming
Business Description
Arbutus Biopharma is a clinical-stage company based in Warminster, Pennsylvania, focused on developing new treatments for chronic Hepatitis B. Its two lead drugs work in different ways ? one reduces harmful viral proteins in the body, while the other helps the immune system fight the infection more effectively. The company also holds a licensing agreement with Alnylam Pharmaceuticals to use their drug delivery technology in its products.
